(NOLA-B) Nolato (publ) - Ratings and Ratios
Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0015962477
NOLA-B: Plastic, Silicone, Medical, Packaging, Industrial
Nolato AB (publ) is a global leader in the development, manufacturing, and supply of high-precision plastic, silicone, and thermoplastic elastomer products. The company serves a diverse range of industries, including medical technology, pharmaceuticals, consumer electronics, telecom, automotive, hygiene, and other industrial sectors. With operations spanning Sweden, the Nordic countries, Asia, Europe, North America, and internationally, Nolato has established itself as a key player in advanced polymer solutions.
The companys product portfolio includes consumables and reusable labware for laboratories, such as microtubes, deep-well plates, pipettes, and containers. It also manufactures breathing bags, catheter balloons, and primary pharmaceutical packaging solutions for solids, creams, and ophthalmic products. Additionally, Nolato produces advanced components and subsystems for consumer electronics, including laser applications, fitness trackers, and thermal management solutions. Its automotive division offers EMI shielding, thermal interface materials, and silicone sealing solutions, while its industrial segment supplies components for coffee machines, blenders, and other household appliances.
Nolatos manufacturing capabilities encompass a wide range of technologies, including injection molding, blow molding, compression molding, and dip molding. The company also provides contract manufacturing services, virtual prototyping, tool manufacturing, and assembly solutions. Its expertise in cleanroom production, laser-activated bonding, and design solutions underscores its commitment to innovation and precision. Founded in 1938 and headquartered in Torekov, Sweden, Nolato AB (publ) has a long history of delivering high-quality products tailored to meet the evolving needs of its global customer base.
For more information, visit the companys website: https://www.nolato.com.
Additional Sources for NOLA-B Stock
NOLA-B Stock Overview
| Market Cap in USD | 1,514m |
| Sector | Healthcare |
| Industry | Medical Devices |
| GiC Sub-Industry | Commodity Chemicals |
| IPO / Inception |
NOLA-B Stock Ratings
| Growth Rating | -18.3 |
| Fundamental | 43.3 |
| Dividend Rating | 1.88 |
| Rel. Strength | 2.35 |
| Analysts | - |
| Fair Price Momentum | 50.20 SEK |
| Fair Price DCF | 113.67 SEK |
NOLA-B Dividends
| Dividend Yield 12m | 0.00% |
| Yield on Cost 5y | % |
| Annual Growth 5y | -100.00% |
| Payout Consistency | 82.5% |
NOLA-B Growth Ratios
| Growth Correlation 3m | -83% |
| Growth Correlation 12m | -21.1% |
| Growth Correlation 5y | -55.6% |
| CAGR 5y | 1.83% |
| CAGR/Max DD 5y | 0.03 |
| Sharpe Ratio 12m | -1.62 |
| Alpha | -9.16 |
| Beta | 0.645 |
| Volatility | 38.01% |
| Current Volume | 544.9k |
| Average Volume 20d | 217.7k |
As of May 09, 2025, the stock is trading at SEK 56.35 with a total of 544,896 shares traded.
Over the past week, the price has changed by +5.15%, over one month by +12.63%, over three months by -10.06% and over the past year by -1.81%.
Partly, yes. Based on ValueRay Fundamental Analyses, Nolato (publ) (ST:NOLA-B) is currently (May 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 43.29 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NOLA-B as of May 2025 is 50.20. This means that NOLA-B is currently overvalued and has a potential downside of -10.91%.
Nolato (publ) has no consensus analysts rating.
According to ValueRays Forecast Model, NOLA-B Nolato (publ) will be worth about 55.9 in May 2026. The stock is currently trading at 56.35. This means that the stock has a potential downside of -0.89%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 62.5 | 10.9% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 55.9 | -0.9% |